BBL454
BBL454 (Compound 43) is a Cholecystokinin 2B (CCK2B) receptor agonist. BBL454 induces hyperactivity and improves memory in rat models while it has weak activity on the peripheral CCK2 receptor and no anxiogenic activity. BBL454 increases gastric acid output in anesthetised rat models. BBL454 can be used for diabetes research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C40H54N6O8
- Masse moléculaire:746.89
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
CCKBR |
Chemical Information
-
Masse moléculaire 746.89
-
Formule C40H54N6O8
-
SMILES
CCCCCCC(CC(N[C@@H](CC1=CNC2=C1C=CC=C2)C(N(C)[C@@H](CCCC)C(N[C@@H](CC(O)=O)C(N[C@@H](CC3=CC=CC=C3)C(N)=O)=O)=O)=O)=O)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Bellier B, et al. New CCK2 agonists confirming the heterogeneity of CCK2 receptors: characterisation of BBL454. Naunyn Schmiedebergs Arch Pharmacol. 2004 Nov;370(5):404-13. [Content Brief]
[2]. Kalindjian SB, et al. Strategies for the design of non-peptide CCK2 receptor agonist and antagonist ligand. Curr Top Med Chem. 2007;7(12):1195-204. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)